Celcuity ( (CELC) ) is experiencing volatility. Read on for a possible explanation for the stock’s unusual movement.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Celcuity Inc.’s stock has seen an unusual movement due to the promising clinical trial results for its drug, gedatolisib, in combination therapies. The trials, VIKTORIA-1 and Phase 1, showed significant improvements in progression-free survival and objective response rates for breast cancer patients. This positive data has boosted optimism about Celcuity’s potential in treating hormone receptor-positive and advanced breast cancer, leading to a favorable market sentiment toward the company’s stock.
More about Celcuity
YTD Price Performance: 295.73%
Average Trading Volume: 1,585,596
Technical Sentiment Signal: Buy
Current Market Cap: $2.2B
For further insights into CELC stock on TipRanks’ Stock Analysis page.
See more of today’s top stock gainers and losers.